Selective Serotonin Reuptake Inhibitors (SSRIs) and Borderline Personality Disorder
Selective serotonin reuptake inhibitors (SSRIs) balance
brain chemicals called
neurotransmitters. Balancing these brain chemicals can
relieve symptoms of
borderline personality disorder such as irritability,
anger, impulsive behavior, and depression.
Some examples of SSRIs
that may be used to treat borderline personality disorder are:
- Sertraline (Zoloft).
- Fluoxetine
(such as Prozac).
- Paroxetine (Paxil).
- Fluvoxamine (such
as Luvox).
- Citalopram (such as Celexa).
- Escitalopram
(Lexapro).
SSRIs are often the first medicine used to treat borderline
personality disorder, because they often are effective and have few side
effects.1
Side effects of selective
serotonin reuptake inhibitors include:
- Nausea, loss of appetite, diarrhea, or weight
gain.
- Anxiety or irritability.
- Problems sleeping or
drowsiness.
- Loss of sexual desire or ability.
- Headaches
or dizziness.
SSRIs can take several weeks to start working, although they
may be effective sooner.
Never suddenly stop taking antidepressants. Many antidepressants should be tapered off
slowly and only under the supervision of a doctor. Abruptly stopping
antidepressant medicines can cause negative side effects or a return of
symptoms of borderline personality disorder.
FDA Advisories. The U.S. Food and Drug Administration (FDA) has
issued:
- An
advisory on antidepressant medicines and the risk of
suicide. The FDA does not recommend that people stop using these medicines.
Instead, a person taking antidepressants should be watched for
warning signs of suicide. This is especially important
at the beginning of treatment or when doses are changed.
- A warning
about taking triptans, used for headaches, with SSRIs (selective serotonin
reuptake inhibitors) or SNRIs (selective serotonin/norepinephrine reuptake
inhibitors). Taking these medicines together can cause a very rare but serious
condition called serotonin syndrome.
Citations
-
American Psychiatric Association (2001). Practice
guidelines for the treatment of patients with borderline personality disorder.
American Journal of Psychiatry, 158(10): 1–52.
|
By
|
Healthwise Staff |
|
Primary Medical Reviewer
|
Sarah Marshall, MD - Family Medicine |
|
Specialist Medical Reviewer
|
Lisa S. Weinstock, MD - Psychiatry |
|
Last Revised
|
March 14, 2011 |
Last Revised:
March 14, 2011
American Psychiatric Association (2001). Practice
guidelines for the treatment of patients with borderline personality disorder.
American Journal of Psychiatry, 158(10): 1–52.